This article on Epainassist.com has been review by a medical professional , as well as chink for facts , to ensure the readers the best potential accuracy .

We espouse a exacting editorial policy and we have a zero - tolerance insurance policy regarding any level of plagiarism . Our articles are resourced from reputable online page . This clause may contains scientific references . The number in the divagation ( 1 , 2 , 3 ) are clickable links to peer - go over scientific paper .

The feedback tie-in “ Was this clause Helpful ” on this varlet can be used to report content that is not exact , up - to - date or questionable in any manner .

Fatty Liver Disease (FLD)

This clause does not offer aesculapian advice .

Fatty Liver Disease ( FLD ) is stimulate by accumulation of blubber in liver cells . fat liver disease is reversible disease . It is in general caused when an mortal consume more rich than the body can handle . It is usually a benign condition but if not treated appropriately may lead to complicatedness . In this clause , we will read about the various causes , symptom , and discussion for Fatty Liver Disease ( FLD ) .

How Is Fatty Liver Disease (FLD) Defined?

Causes of Fatty Liver Disease (FLD)

Non-alcoholic Fatty Liver Genetic Predisposition3

Fatty Liver Disease (FLD) Caused Due To Obesity:

Fatty Liver Disease (FLD) Caused By Alcohol Consumption

Drugs and Medications Causing Fatty Liver Disease (FLD)

Endocrinal Disease Causing Fatty Liver Disease (FLD)-

Abnormal Fat Metabolism Causing Fatty Liver Disease (FLD)-

Risk Factors Of Fatty Liver Disease (FLD)

Symptoms Of Fatty Liver Disease (FLD)

Non-Specific Symptoms of Fatty Liver Disease (FLD)-

Specific Symptoms and Signs of Fatty Liver Disease (FLD)-

Diagnosis Of Fatty Liver Disease (FLD)

Urine Examination

Blood Examination

Radiological Studies-

Treatment For Fatty Liver Disease (FLD)

Prevention Of Fatty Liver Disease (FLD)

for prevent Fatty Liver Disease from come one can follow the following guidelines

extension :

1 . Nonalcoholic fatty liver disease : diagnosis and direction .

Wilkins T1 , Tadkod A , Hepburn I , Schade RR .

Am Fam Physician . 2013 Jul 1;88(1):35 - 42 .

2 . Involvement of the mitochondrial permeableness transition stomate in chronic ethanol - mediated liver harm in mice .

King AL1 , Swain TM , Mao Z , Udoh US , Oliva CR , Betancourt AM , Griguer CE , Crowe DR , Lesort M , Bailey SM .

Am J Physiol Gastrointest Liver Physiol . 2014 Feb 15;306(4):G265 - 77 .

3 . Exome - wide tie-up subject area identifies a TM6SF2 var. that consult susceptibility to nonalcoholic fatty liver disease .

Kozlitina J1 , Smagris E1 , Stender S2 , Nordestgaard BG3 , Zhou HH4 , Tybjærg - Hansen A5 , Vogt TF4 , Hobbs HH6 , Cohen JC

Nat Genet . 2014 Apr;46(4):352 - 6 .

4 . genetical variant in GCKR and PNPLA3 confer susceptibility to nonalcoholic fatty liver disease in obese individuals .

Lin YC1 , Chang PF , Chang MH , Ni YH .

Am J Clin Nutr . 2014 Apr;99(4):869 - 74 .

5 . Nutrigenomics of high fat diet induced obesity in mice suggests relationships between susceptibility to fatty liver disease and the proteasome .

Waller - Evans H1 , Hue C , Fearnside J , Rothwell AR , Lockstone HE , Caldérari S , Wilder SP , Cazier JB , Scott J , Gauguier D.

PLoS One . 2013 Dec 6;8(12 ) .